DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹358 Cr |
Mar2024 | ₹239 Cr |
Mar2023 | ₹345 Cr |
Mar2022 | ₹292 Cr |
Mar2021 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹358 Cr | 49.78 | |
Mar2024 | ₹239 Cr | -30.74 | |
Mar2023 | ₹345 Cr | 18.25 | |
Mar2022 | ₹292 Cr | 29.07 | |
Mar2021 | ₹226 Cr | - |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹24,524.1 Cr | -1.7% | 4.7% | 7.2% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹119,107.0 Cr | 3.4% | 3.2% | 43.3% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹100,724.0 Cr | 1.1% | 0.4% | 15.2% | Stock Analytics | |
FORTIS HEALTHCARE | ₹57,520.3 Cr | -0.3% | 11.2% | 63.3% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹38,881.7 Cr | 3.7% | 8.6% | 55.1% | Stock Analytics | |
GLOBAL HEALTH | ₹31,861.8 Cr | -0.9% | 0.3% | -2% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -1.7% |
4.7% |
7.2% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses